BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Chun-Ming Hong, Chun-Jen Liu, Shiou-Hwei Yeh, Pei-Jer Chen. Addition of ribavirin to daclatasvir plus asunaprevir for chronic hepatitis C 1b patients with baseline NS5A resistance-associated variants improved responseJournal of the Formosan Medical Association 2017; 116(4): 295 doi: 10.1016/j.jfma.2016.11.014
2
Tessa M Nápoles, Abigail W Batchelder, Ada Lin, Lissa Moran, Mallory O Johnson, Martha Shumway, Anne F Luetkemeyer, Marion G Peters, Kellene V Eagen, Elise D Riley. HCV treatment barriers among HIV/HCV co-infected patients in the US: a qualitative study to understand low uptake among marginalized populations in the DAA eraJournal of Public Health 2019;  doi: 10.1093/pubmed/fdz045
3
Zijian Qin, Maolin Wang, Aixia Yan. QSAR studies of the bioactivity of hepatitis C virus (HCV) NS3/4A protease inhibitors by multiple linear regression (MLR) and support vector machine (SVM)Bioorganic & Medicinal Chemistry Letters 2017; 27(13): 2931 doi: 10.1016/j.bmcl.2017.05.001
4
Stefania Notari, Massimo Tempestilli, Gabriele Fabbri, Raffaella Libertone, Andrea Antinori, Adriana Ammassari, Chiara Agrati. UPLC–MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patientsJournal of Chromatography B 2018; 1073: 183 doi: 10.1016/j.jchromb.2017.12.018
5
Molham Abdulsamad, Ariyo Ihimoyan. Viekira Pak Induced Fatal Lactic Acidosis: A Case Report of an Unusual Side EffectCase Reports in Hepatology 2016; 2016: 1 doi: 10.1155/2016/8627139
6
Naser F. Al-Tannak, Ahmed Hemdan, Maya S. Eissa. Development of a Robust UPLC Method for Simultaneous Determination of a Novel Combination of Sofosbuvir and Daclatasvir in Human Plasma: Clinical Application to Therapeutic Drug MonitoringInternational Journal of Analytical Chemistry 2018; 2018: 1 doi: 10.1155/2018/6535816
7
Angel Hernández-Bartolomé, Rosario López-Rodríguez, María Jesús Borque, Leticia González-Moreno, Yolanda Real-Martínez, Luisa García-Buey, Ricardo Moreno-Otero, Paloma Sanz-Cameno. Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis CWorld Journal of Gastroenterology 2016; 22(44): 9744-9751 doi: 10.3748/wjg.v22.i44.9744
8
Giulia Malaguarnera, Gaetano Bertino, Giuseppe Chisari, Massimo Motta, Michele Vecchio, Marco Vacante, Filippo Caraci, Carmela Greco, Filippo Drago, Giuseppe Nunnari, Michele Malaguarnera. Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work abilityBMC Psychiatry 2016; 16(1) doi: 10.1186/s12888-016-1115-z
9
Giulia Malaguarnera, Gaetano Bertino, Carmela Greco, Caterina Gagliano, Massimo Motta, Giuseppe Chisari, Venerando Rapisarda, Giuseppe Nunnari, Michele Vecchio, Filippo Drago, Michele Malaguarnera. Job performance in chronic hepatitis C virus patients treated with pegylated interferon-α2b plus ribavirin: an observational studyTranslational Medicine Communications 2017; 2(1) doi: 10.1186/s41231-016-0010-4
10
Amanda Chaney. Caring for patients with chronic hepatitis C infectionNursing 2019; 49(3): 36 doi: 10.1097/01.NURSE.0000553271.39804.a4
11
Jeffrey L. Roberson, Alicia M. Lagasca, Virginia L. Kan. Comparison of the Hepatitis C Continua of Care Between Hepatitis C Virus/HIV Coinfected and Hepatitis C Virus Mono-Infected Patients in Two Treatment Eras During 2008–2015AIDS Research and Human Retroviruses 2018; 34(2): 148 doi: 10.1089/aid.2017.0092
12
S Amele, L Peters, M Sluzhynska, A Yakovlev, A Scherrer, P Domingo, J Gerstoft, JP Viard, M Gisinger, R Flisiak, S Bhaghani, M Ristola, C Leen, E Jablonowska, G Wandeler, H Stellbrink, K Falconer, A D'Arminio Monforte, A Horban, JK Rockstroh, JD Lundgren, A Mocroft. Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDAHIV Medicine 2019; 20(4): 264 doi: 10.1111/hiv.12711
13
Marleen H. M. Hessel, Adam F. Cohen, Robert Rissmann. Sofosbuvir and daclatasvirBritish Journal of Clinical Pharmacology 2016; 82(3): 878 doi: 10.1111/bcp.13011
14
Rosario López-Rodríguez, Ángel Hernández-Bartolomé, María Jesús Borque, Yolanda Rodríguez-Muñoz, Samuel Martín-Vílchez, Luisa García-Buey, Leticia González-Moreno, Yolanda Real-Martínez, Paloma Muñoz de Rueda, Javier Salmerón, José Ramón Vidal-Castiñeira, Carlos López-Larrea, Luis Rodrigo, Ricardo Moreno-Otero, Paloma Sanz-Cameno, Matias A. Avila. Interferon-related genetic markers of necroinflammatory activity in chronic hepatitis CPLOS ONE 2017; 12(7): e0180927 doi: 10.1371/journal.pone.0180927
15
Gaetano Bertino, Giulia Malaguarnera, Evelise Frazzetto, Alice Sciuto, Gaetano Inserra, Guido Nicola Zanghì, Michele Malaguarnera. Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutionsWorld Journal of Hepatology 2018; 10(6): 448-451 doi: 10.4254/wjh.v10.i6.448
16
Ángel Hernández-Bartolomé, Rosario López-Rodríguez, Luisa García-Buey, Samuel Martín-Vílchez, Yolanda Rodríguez-Muñoz, María Jesús Borque, Leticia González-Moreno, Yolanda Real-Martínez, Jorge Mendoza-Ridruejo, Elena Martín-Pérez, Ricardo Moreno-Otero, Paloma Sanz-Cameno. Intrahepatic angiopoietin-2 correlates with chronic hepatitis C progression and is induced in hepatitis C virus replicon systemsLiver International 2017; 37(8): 1148 doi: 10.1111/liv.13352
17
Venerando Rapisarda, Carla Loreto, Michele Malaguarnera, Annalisa Ardiri, Maria Proiti, Giuseppe Rigano, Evelise Frazzetto, Maria Irene Ruggeri, Giulia Malaguarnera, Nicoletta Bertino, Mariano Malaguarnera, Vito Emanuele Catania, Isidoro Di Carlo, Adriana Toro, Emanuele Bertino, Dario Mangano, Gaetano Bertino. Hepatocellular carcinoma and the risk of occupational exposureWorld Journal of Hepatology 2016; 8(13): 573-590 doi: 10.4254/wjh.v8.i13.573
18
Ricard Masia, Joseph Misdraji. Diagnostic Pathology of Infectious Disease2018; : 272 doi: 10.1016/B978-0-323-44585-6.00011-4
19
Rosario Gravier-Hernández, Lizette Gil-del Valle, Lindunka Valdes-Alonso, Nadiecha Hernández-Ayala, Yusimit Bermúdez-Alfonso, Daymé Hernández-Requejo, Teresa Rosell-Guerra, Maria C. Hernández-González-Abreu. Oxidative stress in hepatitis C virus–human immunodeficiency virus co-infected patientsAnnals of Hepatology 2019;  doi: 10.1016/j.aohep.2019.05.009
20
Manal El‐Hamamsy, Iman Fawzy Montasser, Azza El‐Sayed Mansy, Dina Ezzeldin Nabet, Mahmoud El‐Meteini. Effect of cyclosporine A versus tacrolimus on the response to antiviral therapy after hepatitis C genotype‐4 recurrence post–liver transplantation: A prospective cohort trialJournal of Clinical Pharmacy and Therapeutics 2019; 44(3): 447 doi: 10.1111/jcpt.12807
21
Juliana Cristina Santiago Bastos, Marina Aiello Padilla, Leonardo Cardia Caserta, Noelle Miotto, Aline Gonzalez Vigani, Clarice Weis Arns. Hepatitis C virus: Promising discoveries and new treatmentsWorld Journal of Gastroenterology 2016; 22(28): 6393-6401 doi: 10.3748/wjg.v22.i28.6393
22
Serap Beldar, Malathy Sony Subramanian Manimekalai, Nam-Joon Cho, Kwanghee Baek, Gerhard Grüber, Ho Sup Yoon. Self-association and conformational variation of NS5A domain 1 of hepatitis C virus Journal of General Virology 2018; 99(2): 194 doi: 10.1099/jgv.0.001000
23
Marianna Zając, Izabela Muszalska, Agnieszka Sobczak, Adrianna Dadej, Szymon Tomczak, Anna Jelińska. Hepatitis C – New drugs and treatment prospectsEuropean Journal of Medicinal Chemistry 2019; 165: 225 doi: 10.1016/j.ejmech.2019.01.025
24
Chun-Ming Hong, Chen-Hua Liu, Tung-Hung Su, Hung-Chih Yang, Pei-Jer Chen, Yu-Wen Chen, Jia-Horng Kao, Chun-Jen Liu. Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world dataJournal of Microbiology, Immunology and Infection 2018;  doi: 10.1016/j.jmii.2018.09.005
25
Helena H.L. Borba, Ursula Rochau, Astrid Wiens, Gaby Sroczynski, Uwe Siebert, Vinicius L. Ferreira, Eimy Minowa, Roberto Pontarolo. Effectiveness and Cost-Effectiveness of Triple Therapy with Telaprevir and Boceprevir for Chronic Hepatitis C: A Decision Analysis from the Brazilian Public Health System PerspectiveValue in Health Regional Issues 2019; 20: 95 doi: 10.1016/j.vhri.2019.02.005
26
Sern Wei Yeoh, Alex C. N. Holmes, Michael M. Saling, Ian P. Everall, Amanda J. Nicoll. Depression, fatigue and neurocognitive deficits in chronic hepatitis CHepatology International 2018; 12(4): 294 doi: 10.1007/s12072-018-9879-5
27
Waleed A. Ismail, Ayman E. Yousef. Effect of sofosbuvir plus daclatasvir for treatment of chronic hepatitis C on patients with psoriasisEuropean Journal of Gastroenterology & Hepatology 2019; 31(8): 1025 doi: 10.1097/MEG.0000000000001370
28
Jeffrey L. Roberson, Virginia L. Kan. Hepatitis C Virus Continuum of Care in the Interferon and Direct-Acting Agent Eras Among HIV-Coinfected PatientsAIDS Research and Human Retroviruses 2017; 33(5): 405 doi: 10.1089/aid.2016.0170
29
Manuela Pennisi, Gaetano Bertino, Caterina Gagliano, Michele Malaguarnera, Rita Bella, Antonio Borzì, Roberto Madeddu, Filippo Drago, Giulia Malaguarnera. Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep DisturbanceNutrients 2017; 9(8): 897 doi: 10.3390/nu9080897
30
Ossama Ashraf Ahmed, Eslam Safwat, Mohamed Omar Khalifa, Ahmed I. Elshafie, Mohamed Hassan Ahmed Fouad, Mohamed Magdy Salama, Gina Gamal Naguib, Mohamed Mahmoud Eltabbakh, Ahmed Fouad Sherief, Sherief Abd-Elsalam. Sofosbuvir Plus Daclatasvir in Treatment of Chronic Hepatitis C Genotype 4 Infection in a Cohort of Egyptian Patients: An Experiment the Size of Egyptian VillageInternational Journal of Hepatology 2018; 2018: 1 doi: 10.1155/2018/9616234
31
Biophysical Mode-of-Action and Selectivity Analysis of Allosteric Inhibitors of Hepatitis C Virus (HCV) PolymeraseViruses 2017; 9(6): 151 doi: 10.3390/v9060151
32
J. Bagg, K. Roy, L. Hopps, I. Black, D. Croser, C. O'Halloran, F. Ncube. No longer 'written off' – times have changed for the BBV-infected dental professionalBritish Dental Journal 2017; 222(1): 47 doi: 10.1038/sj.bdj.2017.36
33
Sebastián Marciano, Leila Haddad, Fernando Plazzotta, Ezequiel Mauro, Sergio Terraza, Sanjeev Arora, Karla Thornton, Beatriz Ríos, Carlos García Dans, Natalia Ratusnu, Liliana Calanni, José Allevato, María Ester Sirotinsky, Marcos Pedrosa, Adrián Gadano. Implementation of the ECHO®telementoring model for the treatment of patients with hepatitis CJournal of Medical Virology 2017; 89(4): 660 doi: 10.1002/jmv.24668
34
Federico Salomone, Maurizio Catania, Arturo Montineri, Gaetano Bertino, Justyna Godos, Leonardo Rizzo, Giovanni Magrì, Giovanni Li Volti. Hepatitis C virus eradication by direct antiviral agents improves glucose tolerance and reduces post-load insulin resistance in nondiabetic patients with genotype 1Liver International 2018; 38(7): 1206 doi: 10.1111/liv.13669
35
Yuqian Yan, Ning Liang, Shibing Liang, Yuxin Sun, Nicola Robinson, Jianping Liu. Evaluation of outcomes reported in randomized controlled trials for herbal remedies for adults with chronic hepatitis CJournal of Traditional Chinese Medical Sciences 2019; 6(2): 115 doi: 10.1016/j.jtcms.2019.03.002
36
R. Ragusa, G. Bertino, A. Bruno, E. Frazzetto, F. Cicciu, G. Giorgianni, L. Lupo. Evaluation of health status in patients with hepatitis c treated with and without interferonHealth and Quality of Life Outcomes 2018; 16(1) doi: 10.1186/s12955-018-0842-x